Response to Letter Regarding Article, “Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: An analysis of the third international stroke trial”

Ítems similars

• Targeting rtPA in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the IST-3 trial
  per: Whiteley, William N., et al.
  Publicat: (2014)
• Response to letter regarding article, “Patterns and Implications of Intracranial Arterial Remodeling in Stroke Patients”
  per: Qiao, Ye, et al.
  Publicat: (2016)
• Response by Barreto and Grotta to Letter Regarding Article, "Randomized, multicenter trial of ARTSS-2 (argatroban with recombinant tissue plasminogen activator for acute stroke)"
  per: Barreto, Andrew D., et al.
  Publicat: (2017)
• Antiplatelet Therapy and the Risk of Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
  per: Hallevi, Hen, et al.
  Publicat: (2008)
• Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke
  per: Roth, Jennifer M.
  Publicat: (2011)